To identify streptococcal genes that are expressed during experimental endocarditis, we developed a promoter-less dual reporter gene-fusion (amy, cat) plasmid, pAK36. Chromosomal DNA from S. gordonii V288 was digested with Sau3Al. The resulting fragments were ligated into pAK36. Following transformation into S. gordonii, the library of random gene fusion clones was inoculated into a rabbit to induce experimental endocarditis. Chloramphenicol treatment effected positive selection. Upon euthanization of the rabbits, the valvular vegetations were excised in a sterile field. Surviving clones were isolated and screened in vitro for chloramphenicol sensitivity and negative amylase activity. From the 48 randomly picked, double-negative clones. DNA was isolated and analyzed by Southern hybridization with labeled pAK36 probe. Different insertion patterns were identified, suggesting that no fewer than 13 S. gordonii genes were induced. Therefore, S. gordonii genes are induced during experimental endocarditis, which may contribute to virulence.
Angrist AA, Oka M., Nakao K. (1967). Vegetative endocarditis. Pathol Ann2:155-212.
2.
Baddour LM (1994). Virulence factors among Gram-positive bacteria in experimental endocarditits. Infect Immun62:2143-2148.
3.
Baddour LM, Christensen GD, Lowrence JH, Simpson WA (1989) Pathogenesis of experimental endocarditis. Rev Infect Dis11:452-463.
4.
Bancsi Mjlmf, Thompson J., Bertina RM (1994). Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun62:5669-5672.
5.
Bancsi Mjlmf, Veltrop Mham, Bertina RM, Thompson J. (1996). Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis. Infect Immun64:448-451.
6.
Bennett IL, Beeson PB (1954). Bacteremia: A consideration of some experimental and clinical aspects. Yale J Biol Med26:241-262.
7.
Burnette-Curley D., Wells V., Viscount H., Munro CL, Fenno JC, Fives-Taylor P., et al. (1995). FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun63:4669-4674.
8.
Costalonga M., Powdrill JM, Herzberg MC, Schlievert PM (1994). Pyrogenic exotoxins and the pathogenesis of Streptococcus sanguis endocarditis (abstract). J Dent Res73(Spec Iss):426.
9.
Dall LH, Herndon BL (1990). Association of cell-adherent glycocalyx and endocarditis production by viridans group streptococci. J Clin Microbiol28:1698-1700.
10.
Dankert J., VanderWerff J., Zaat Saj, Joldersma W., Klein D., Hess J. ( 1995). Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun63:663-671.
11.
Durack DT (1990). Infective and noninfective endocarditis. In: The heart, arteries and veins. 7th ed. Vol. 2. Hurst JW , Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK, editors. New York: McGraw-Hill, pp. 1230-1255.
12.
Durack DT (1995). Prevention of infective endocarditis. New Engl J Med332:38-44.
13.
Durack DT, Beeson PB (1972). Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol53:44-49.
14.
Erickson PR, Herzberg MC (1987). A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregation. J Immunol138:3360-3366.
15.
Erickson PR, Herzberg MC (1990). Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J Biol Chem265:14080-14087.
16.
Erickson PR, Herzberg MC (1993a). The Streptococcus sanguis platelet aggregation-associated protein: Identification and characterization of the minimal platelet-interactive domain. J Biol Chem268:1646-1649.
17.
Erickson PR, Herzberg MC (1993b). Evidence for the covalent linkage of carbohydrate polymers to a glycoprotein from Streptococcus sanguis. J Biol Chem268:23780-23783.
18.
Erickson PR, Herzberg MC (1995). Altered expression of the platelet aggregation-associated protein from Streptococcus sanguis after growth in the presence of collagen . Infect Immun63:1084-1088.
19.
Erickson PR, Herzberg MC, Tierney G. (1992). Crossreactive immunodeterminants on Streptococcus sanguis and collagen: Predicting the structure of platelet-interactive domains . J Biol Chem267:10018-10023.
20.
Ford I., Douglas Cwi, Preston FE, Lawless A., Hampton KK (1993). Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditits. Br J Haematol84:95-100.
21.
Gong K., Wen DY, Ouyang T., Rao AT, Herzberg MC (1995). Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies. Infect Immun63:3628-3633.
22.
Herzberg MC (1996). Platelet-streptococcal interactions in endocarditis . Crit Rev Oral Biol Med7:222-236.
23.
Herzberg MC, Brintzenhofe KL (1983). ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP. Infect Immun40:120-125.
24.
Herzberg MC, Brintzenhofe KL, Clawson CC (1983a). Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun39:1457-1469.
25.
Herzberg MC, Brintzenhofe KL, Clawson CC (1983b). Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation. Infect Immun42:394-401.
26.
Herzberg MC, Macfarlane GD, Delzer PR (1985). Streptococcus sanguis interactions with human platelets. In: Molecular basis for oral microbial adhesion . Mergenhagen S, Rosan B, editors. Washington, DC: Am Soc Microbiol, pp. 53-60.
27.
Herzberg MC, Gong K., Macfarlane GD, Erickson PR, Soberay AH, Krebsbach PH, et al. (1990a). Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun58:515-522.
28.
Herzberg MC, Erickson PR, Kane PK, Clawson DJ, Clawson CC, Hoff FA ( 1990b). Platelet-interactive products of Streptococcus sanguis protoplasts. Infect Immun58 :4117-4125.
29.
Herzberg MC, Macfarlane GD, Gong K., Armstrong NN, Witt AR, Erickson PR, et al. (1992). Platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immun60:4809-4818.
30.
Lehner T., Lavery E., Smith R., van der Zee R., Mizushima Y., Shinnick T. (1991). Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome. Infect Immun59:1434-1441.
31.
Liu P., Herzberg MC (1995). Partial sequence of a 65 kDa heat shock protein gene homolog from Streptococcus sanguis (abstract). J Dent Res74(Spec Iss):465.
32.
Liu P., Gong K., Costalonga M., Herzberg MC (1995). The heat shock response of PAAP-related protein of Streptococcus sanguis (abstract). J Dent Res74(Spec Iss):56.
33.
Lowrance JH, Baddour LM, Simpson WA (1990). The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. J Clin Invest86:7-13.
34.
Macfarlane GD, Sampson DE, Clawson DJ, Clawson CC, Kelly KL, Herzberg MC (1994). Evidence for an ectoATPase on the cell wall of Streptococcus sanguis. Oral Microbiol Immunol9:180-185.
35.
Mahan MJ, Slauch JM, Mekalanos JJ (1993). Selection of bacterial virulence genes that are specifically induced in host tissues. Science259:686-688.
36.
Matsushita M., Fujimaki W., Kato H., Uchiyama T., Igarashi H., Ohkuni H., et al. (1995). Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect Immun63:785-793.
37.
Mayo JA, Zhu H., Harty Dws, Knox KW ( 1995). Modulation of glycosidase and protease activities by chemostat growth conditions in an endocarditis strain of Streptococcus sanguis . Oral Microbiol Immunol10:342-348.
38.
Meyer MW, Witt AR, Krishnan LK, Yokota M., Roszkowski MI, Rudney JD, et al. (1995). Therapeutic advantage of recombinant human tissue plasminogen activator in endocarditis: evidence from experimental rabbits . Thromb Haemost73:680-682.
39.
Mghir AS, Cremieux AC, Jambour R., Muffat-Joly M., Pocidalo JJ, Carbon C. (1994). Dextranase enhances antibiotic efficacy in experimental viridans streptococcal endocarditits. Antimicrob Agents Chemother38:953-958.
40.
Munro CL, Macrina FL (1993). Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis. Molec Microbiol8:133-142.
41.
Sande MA, Scheld WM (1980). Bacterial adherence in endocarditis. Interaction of bacterial dextran, platelets, fibrin, and antibody. Scand J Infect Dis(Suppl24):100-105.
42.
Scheld WM, Valone JA, Sande MA (1978). Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets and fibrin. J Clin Invest61:1394-1404.
43.
Soberay AH, Herzberg MC, Rudney JD, Nieuwenhuis HK, Sixma JJ, Seligsohn U. (1987). Responses of platelets to strains of Streptococcus sanguis. Findings in healthy subjects, Bernard-Soulier, Glanzmann's and collagen-unresponsive patients. Thromb Haemost57:222-225.
44.
Sommer P., Gleyzal C., Guerret S., Etienne J., Grimaus J-A (1992). Induction of a putative laminin-binding protein of Streptococcus gordonii in human infective endocarditis. Infect Immun60:360-365.
45.
Straus DC (1982). Protein production by Streptococcus sanguis associated with subacute bacterial endocarditis. Infect Immun38:1037-1045.
46.
Wells VD, Munro CL, Sulavik MC, Clewell DB, Macrina FL (1993). Infectivity of a glucan synthesis-defective mutant of Streptococcus gordonii [Challis] in a rat endocarditis model. FEMS Microbiol Lett112:301-306.
47.
Wu T., Yeaman MR, Bayer AS (1994). In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother38:729-732.
